Post by
Redrum180 on Jul 07, 2021 3:40pm
Huge Disappointment
Has it crossed anyone's mind that if this technology is what the company says it is, it should be attracting more interest in the market and by competitors?
Why wouldn't DermTech make a buyout offer for MEDX if they can analyze skin lesions more cheaply and effectively? Could one or more of their patents be problematic? I would love to know why DermTech has shown what seems to be zero interest in acquiring this company.
I am long this company's shares and want them to be successful but the caginess of management is worrisome and the lack of interest by DermTech is not helping. Hopefully this stock simply hasn't appeared on their radar. If I were DermTech management, I'd take a good, hard look at Medx. In the meantime, I'm taking an unwelcome beating. The only thing that kept me from going in more heavily was the lack of US volume.
I'd appreciate any feedback on my points. GLTA longs.
Comment by
Bogeyfree1 on Jul 08, 2021 8:46pm
Insightful1, I would really appreciate your thoughts on the points raised by Redrum 180. TY
Comment by
Bogeyfree1 on Jul 09, 2021 10:17am
Thank you for your quick reply! You wrote: " it would be a shame if MDX was acquired at say .50 ..... " To be honest, right now after all these years of waiting and not knowing exactly where the company stands, I would gladly welcome such an offer! But that just me! Thanks again!
Comment by
Insightful1 on Jul 09, 2021 3:17pm
I hear you but look at DermTech share price it went along forever then absolutely broke out. It is what I believe is about to happen to MedX. Keep the faith.
Comment by
Rubberband on Jul 11, 2021 9:36pm
As Mr. Passy said yrs ago this will be a $5 stock. Yes 22 yrs later and not there yet but I believe we are now in the right direction.